E. Bilianou

594 total citations
8 papers, 90 citations indexed

About

E. Bilianou is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Bilianou has authored 8 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Bilianou's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). E. Bilianou is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). E. Bilianou collaborates with scholars based in Greece and United Kingdom. E. Bilianou's co-authors include Evangelos Liberopoulos, Moses Elisaf, Vasilios G. Athyros, Κωνσταντίνος Τζιόμαλος, Dimitri P. Mikhailidis, Apostolos Achimastos, Theodore K. Alexandrides, Emmanuel S. Ganotakis, Christos V. Rizos and Matilda Florentin and has published in prestigious journals such as Atherosclerosis, Current Pharmaceutical Design and Lipids.

In The Last Decade

E. Bilianou

8 papers receiving 89 citations

Peers

E. Bilianou
Lamija Ferhatbegović Bosnia and Herzegovina
Yadong Yang United States
Ronald M. Krauss United States
E. Bilianou
Citations per year, relative to E. Bilianou E. Bilianou (= 1×) peers Jiamin Liu

Countries citing papers authored by E. Bilianou

Since Specialization
Citations

This map shows the geographic impact of E. Bilianou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bilianou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bilianou more than expected).

Fields of papers citing papers by E. Bilianou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bilianou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bilianou. The network helps show where E. Bilianou may publish in the future.

Co-authorship network of co-authors of E. Bilianou

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bilianou. A scholar is included among the top collaborators of E. Bilianou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bilianou. E. Bilianou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Anagnostis, Panagiotis, Christos V. Rizos, Ioannis Skoumas, et al.. (2021). Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH. Current Pharmaceutical Design. 27(21). 2537–2544. 2 indexed citations
2.
Rizos, Christos V., Ioannis Skoumas, Lοukianos S. Rallidis, et al.. (2021). Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH. Atherosclerosis. 331. e185–e186. 1 indexed citations
3.
Rizos, Christos V., Vasilios G. Athyros, E. Bilianou, et al.. (2017). An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). HORMONES. 13(3). 200–204. 1 indexed citations
4.
Rizos, Christos V., Vasilios G. Athyros, E. Bilianou, et al.. (2017). An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). HORMONES. 16(3). 306–312. 6 indexed citations
5.
Florentin, Matilda, Moses Elisaf, Christos V. Rizos, et al.. (2016). l‐Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double‐Blind Placebo‐Controlled Study. Lipids. 52(1). 1–9. 20 indexed citations
6.
Athyros, Vasilios G., Emmanuel S. Ganotakis, Genovefa Kolovou, et al.. (2011). Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women. Current Vascular Pharmacology. 9(6). 647–657. 33 indexed citations
7.
Athyros, Vasilios G., Moses Elisaf, Theodore K. Alexandrides, et al.. (2011). Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome. Angiology. 63(5). 358–366. 20 indexed citations
8.
Bilianou, E., et al.. (2001). The Prognostic Significance of Atrial Arrhythmias Recorded Early After Cardioversion for Atrial Fibrillation. Pacing and Clinical Electrophysiology. 24(7). 1076–1081. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026